Shypd.aiThe largest open index of AI toolsimmunitoAI is a Pharma & Biotech tool that develops AI-generated novel antibody therapeutics. It focuses on designing antibodies with pre-defined drug properties for various protein targets.
Trending
About
immunitoAI is a TechBio company specializing in the development of AI-generated novel antibody therapeutics. Their platform focuses on 'Design over Discovery,' creating antibodies in silico without relying on biological sources, which aims to increase efficiency and expand the antibody space beyond natural repertoires. The company emphasizes 'Drug-First Antibodies,' embedding pre-defined drug properties at the inception of the design process to minimize the exploratory phase in drug developability. Utilizing a 'Structure-First AI Platform,' their neural networks are trained on shape complementarity for precise, target-specific design, optimizing affinity and specificity, and potentially opening possibilities for previously undruggable targets. immunitoAI's vision is to make antibody therapy the norm by unleashing the full potential of antibody-based biological drugs.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check immunitoai.com for current pricing.
FAQs
Trending
